Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2864 Target Snapshot

Methylated-DNA--protein-cysteine methyltransferase · SINGLE PROTEIN · Homo sapiens

187Compounds
85Assays
0Approved Drugs
148.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P16455. Use UniProt P16455 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P16455 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Methylated-DNA--protein-cysteine methyltransferase as ChEMBL target CHEMBL2864, mapped to UniProt P16455. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Methylated-DNA--protein-cysteine methyltransferase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2864
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P16455
Methylated-DNA--protein-cysteine methyltransferase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Methylated-DNA--protein-cysteine methyltransferase is the right protein anchor across sources, using UniProt P16455 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMethylated-DNA--protein-cysteine methyltransferase
UniProt AccessionP16455
Component TypeProtein
Sequence Length207 aa

Methylated-DNA--protein-cysteine methyltransferase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Methylated-DNA--protein-cysteine methyltransferase, mapped to UniProt P16455. Sequence length is 207 aa.

Mapped IDP16455
Review nameMethylated-DNA--protein-cysteine methyltransferase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50147.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL337677 8.52 IC50 3.0 Preclinical
CHEMBL339133 8.52 IC50 3.0 Clinical
CHEMBL146769 8.3 IC50 5.0 Preclinical
CHEMBL485756 8.05 IC50 9.0 Preclinical
CHEMBL151579 7.75 IC50 18.0 Preclinical
CHEMBL4454794 7.62 Ki 24.0 Preclinical
CHEMBL2171205 7.6 IC50 25.0 Preclinical
CHEMBL129850 7.52 IC50 30.0 Preclinical
CHEMBL131510 7.52 IC50 30.0 Preclinical
CHEMBL336947 7.5 IC50 32.0 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
10
5.5
10
6.0
16
6.5
15
7.0
7
7.5
4
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

85
Total Assays
83
Tested Compounds
2
Assay Types
Binding — 83 assays, 83 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 58 47 6.2
single protein format 19 36 6.3
assay format 6 0
ADME — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine